Madrigal Pharmaceuticals Inc (MDGL)
218.26
+4.78
(+2.24%)
USD |
NASDAQ |
Apr 23, 16:00
218.21
-0.06
(-0.03%)
After-Hours: 20:00
Madrigal Pharmaceuticals Cash from Investing (TTM): -502.52M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -502.52M |
| September 30, 2023 | -74.01M |
| June 30, 2023 | -59.07M |
| March 31, 2023 | -36.10M |
| December 31, 2022 | 206.69M |
| September 30, 2022 | 155.94M |
| June 30, 2022 | 130.90M |
| March 31, 2022 | 84.34M |
| December 31, 2021 | -5.055M |
| September 30, 2021 | -25.50M |
| June 30, 2021 | 29.17M |
| March 31, 2021 | 75.86M |
| December 31, 2020 | 159.78M |
| September 30, 2020 | 134.07M |
| June 30, 2020 | 67.58M |
| March 31, 2020 | 84.66M |
| December 31, 2019 | 30.71M |
| September 30, 2019 | 86.20M |
| June 30, 2019 | -164.09M |
| March 31, 2019 | -281.44M |
| December 31, 2018 | -380.08M |
| September 30, 2018 | -398.98M |
| June 30, 2018 | -193.84M |
| March 31, 2018 | -113.57M |
| December 31, 2017 | -22.01M |
| Date | Value |
|---|---|
| September 30, 2017 | -18.01M |
| June 30, 2017 | 10.79M |
| March 31, 2017 | 11.44M |
| December 31, 2016 | 21.99M |
| September 30, 2016 | 11.92M |
| June 30, 2016 | 14.70M |
| March 31, 2016 | -8.317M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -0.93M |
| June 30, 2015 | -51.21M |
| March 31, 2015 | -16.72M |
| December 31, 2014 | -8.837M |
| September 30, 2014 | -23.06M |
| June 30, 2014 | 21.02M |
| March 31, 2014 | 28.16M |
| December 31, 2013 | -24.65M |
| September 30, 2013 | -2.983M |
| June 30, 2013 | -18.32M |
| March 31, 2013 | -33.24M |
| December 31, 2012 | -9.943M |
| September 30, 2012 | 3.524M |
| June 30, 2012 | 17.07M |
| March 31, 2012 | -0.79M |
| December 31, 2011 | 9.329M |
| September 30, 2011 | -11.14M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-502.52M
Minimum
Dec 2023
206.69M
Maximum
Dec 2022
19.98M
Average
67.58M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
| Eli Lilly and Co | -7.153B |
| Viking Therapeutics Inc | -179.09M |
| Akero Therapeutics Inc | -223.62M |
| 89bio Inc | -123.02M |
| Geron Corp | -180.32M |